abstract |
The invention relates to compounds of the formula where the substituents are described in claim 1. The compounds can be used to treat diseases based on inhibition of glycine uptake, such as psychosis, pain, neurodegenerative disorders of memory and learning, schizophrenia, dementia, and other diseases in which cognitive processes such as distracted attention or Alzheimer's disease are impaired. |